Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000018 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 24, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,500
Total Value
$18,957.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Mar 23, 2026 | Exercise/Conversion | 6,500 | $0.06 | $390.00 | 6,500 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Mar 23, 2026 | Sale | 6,500 | $2.86 | $18,567.90 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Mar 23, 2026 | Exercise/Conversion | 6,500 | $0.00 | $0.00 | 267,686 | Direct | โ | View Details |